Clinical Trial Update: Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing intravitreal diclofenac with intravitreal ranibizumab for diabetic macular edema; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Diclofenac (diclofenac)
• Lucentis (ranibizumab)

Snippet

Sponsor: Cairo University | Conditions: Diabetic Macular Edema | Phase 4 | Status: UNKNOWN